Fusions time to shine has arrived15 Nov 2025 11:22
No one is going to be able to churn antibodies without using Optimal at some point in the near future. We have free access to the entire market and when the contracts start landing they will keep on coming. Intelligent investors need to really start connecting the dots of where this is heading. Once the market absorbs what Optimal actually is the Rerate follows in quick succession.
None of us can dispute the capability of optimal, can anyone even name a competitor that even comes remotely close? Thats a challenge for any scientist to answer
The FAB team have validated and made Optimal work, we are on the road to victory.